Daily Stock Analysis, ATRC, AtriCure Inc, priceseries

AtriCure Inc. Daily Stock Analysis
Stock Information
Open
33.35
Close
32.94
High
33.39
Low
32.77
Previous Close
33.34
Daily Price Gain
-0.40
YTD High
33.39
YTD High Date
Feb 14, 2019
YTD Low
28.92
YTD Low Date
Jan 14, 2019
YTD Price Change
2.69
YTD Gain
8.89%
52 Week High
36.49
52 Week High Date
Oct 1, 2018
52 Week Low
16.54
52 Week Low Date
Feb 15, 2018
52 Week Price Change
15.72
52 Week Gain
91.29%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 24. 2017
20.18
May 11. 2017
21.67
13 Trading Days
7.36%
Link
LONG
Jun 16. 2017
21.84
Jul 6. 2017
23.55
13 Trading Days
7.83%
Link
LONG
Sep 15. 2017
21.04
Oct 9. 2017
22.73
16 Trading Days
8.01%
Link
LONG
Feb 14. 2018
16.72
Feb 28. 2018
17.70
9 Trading Days
5.87%
Link
LONG
Mar 6. 2018
18.85
Mar 19. 2018
19.88
9 Trading Days
5.47%
Link
LONG
Jun 12. 2018
24.62
Jun 25. 2018
26.70
9 Trading Days
8.43%
Link
LONG
Aug 21. 2018
31.85
Sep 10. 2018
33.95
13 Trading Days
6.60%
Link
Company Information
Stock Symbol
ATRC
Exchange
NasdaqGM
Company URL
http://www.atricure.com
Company Phone
513-755-4100
CEO
Michael H. Carrel
Headquarters
Ohio
Business Address
7555 INNOVATION WAY, MASON, OH 45040
Sector
separate tissues to provide access to key anatomical structures that are targeted for ablation; and Estech cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. AtriCure sells its products through independent distributors and direct sales personnel. The company was founded in 2000 and is headquartered in Mason, Ohio.
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001323885
About

AtriCure, Inc. engages in the provision of innovative products, professional education, and support for the treatment of atrial fibrillation. Its product, Isolator Synergy Ablation System, is a surgical device that treats the persistent longstanding persistent forms of atrial fibrillation in patients undergoing certain open concomitant procedures. Its cryoICE cryosurgery product offers a variety of cryoablation devices for use in multiple different types of cardiothoracic surgery. Its AtriClip Left Atrial Appendage Exclusion System is designed to occlude the heart's left atrial appendage. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.

Description

AtriCure, Inc. provides atrial fibrillation solutions to medical centers in the United States and internationally. The company offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures, such as coronary artery bypass grafting and/or valve replacement or repair; COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy; and EPi-Sense guided coagulation system used for the temporary cardiac signal sensing and recording during surgery. It also provides SUBTLE cannula, an access device and conduit for the ablation device and endoscope to enable a closed chest endoscopic approach; multifunctional pens that allow surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and linear ablation devices, which enable physicians to create an expanded cardiac ablation lesion set. In addition, the company offers cryoICE cryoablation system used to ablate cardiac tissue for the treatment of cardiac arrhythmias and to provide temporary pain relief to thoracic surgery patients via ablation of peripheral nerves; AtriClip system used to occlude the left atrial appendage by mechanically clamping the appendage; Lumitip dissector to separate tissues to provide access to key anatomical structures that are targeted for ablation; and Estech cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. AtriCure sells its products through independent distributors and direct sales personnel. The company was founded in 2000 and is headquartered in Mason, Ohio.